261 related articles for article (PubMed ID: 2169207)
1. Potent bombesin receptor antagonists distinguish receptor subtypes.
von Schrenck T; Wang LH; Coy DH; Villanueva ML; Mantey S; Jensen RT
Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
[TBL] [Abstract][Full Text] [Related]
2. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
[TBL] [Abstract][Full Text] [Related]
3. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
Amiot F; Leiber D; Marc S; Harbon S
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
[TBL] [Abstract][Full Text] [Related]
4. Contractile effect of bombesin on guinea pig lung in vitro: involvement of gastrin-releasing peptide-preferring receptors.
Lach E; Haddad EB; Gies JP
Am J Physiol; 1993 Jan; 264(1 Pt 1):L80-6. PubMed ID: 8381599
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ability of various substance P antagonists to inhibit action of bombesin.
Jensen RT; Heinz-Erian P; Mantey S; Jones SW; Gardner JD
Am J Physiol; 1988 Jun; 254(6 Pt 1):G883-90. PubMed ID: 2454035
[TBL] [Abstract][Full Text] [Related]
6. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors.
Von Schrenck T; Heinz-Erian P; Moran T; Mantey SA; Gardner JD; Jensen RT
Am J Physiol; 1989 Apr; 256(4 Pt 1):G747-58. PubMed ID: 2539739
[TBL] [Abstract][Full Text] [Related]
7. des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists.
Wang LH; Coy DH; Taylor JE; Jiang NY; Moreau JP; Huang SC; Frucht H; Haffar BM; Jensen RT
J Biol Chem; 1990 Sep; 265(26):15695-703. PubMed ID: 1697594
[TBL] [Abstract][Full Text] [Related]
8. Different receptors mediate the action of bombesin-related peptides on gastric smooth muscle cells.
Severi C; Jensen RT; Erspamer V; D'Arpino L; Coy DH; Torsoli A; Delle Fave G
Am J Physiol; 1991 May; 260(5 Pt 1):G683-90. PubMed ID: 1852115
[TBL] [Abstract][Full Text] [Related]
9. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists.
Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW
Synapse; 1988; 2(3):282-7. PubMed ID: 2463692
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
Severi C; Coy DH; Jensen RT; Boschero L; Anania MC; Delle Fave G
J Pharmacol Exp Ther; 1989 Nov; 251(2):713-7. PubMed ID: 2478696
[TBL] [Abstract][Full Text] [Related]
11. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
[TBL] [Abstract][Full Text] [Related]
12. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity.
Coy DH; Taylor JE; Jiang NY; Kim SH; Wang LH; Huang SC; Moreau JP; Gardner JD; Jensen RT
J Biol Chem; 1989 Sep; 264(25):14691-7. PubMed ID: 2475489
[TBL] [Abstract][Full Text] [Related]
13. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
Patel KV; Schrey MP
J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
[TBL] [Abstract][Full Text] [Related]
14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
16. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
17. Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells.
Coy D; Wang LH; Jiang NY; Jensen R
Eur J Pharmacol; 1990 Nov; 190(1-2):31-8. PubMed ID: 1963850
[TBL] [Abstract][Full Text] [Related]
18. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
[TBL] [Abstract][Full Text] [Related]
19. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
Lin JT; Coy DH; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
[TBL] [Abstract][Full Text] [Related]
20. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.
Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT
Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
